All News

Reimbursement

A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement and Regulatory Approval
7 September 2023
A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement and Regulatory Approval
Miguel Forte, kicks off this
First Person in Europe Commercially Treated with BioMarin’s ROCTAVIAN® for Severe Hemophilia A
31 August 2023
First Person in Europe Commercially Treated with BioMarin’s ROCTAVIAN® for Severe Hemophilia A
BioMarin's ROCTAVIAN gene therapy has
Ready for Market – How Do We Get ATMPs Over the Line in Europe?
8 June 2023
Ready for Market – How Do We Get ATMPs Over the Line in Europe?
Join us as a panel
Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
POPULAR NEWS ITEMS
Image
11 October 2024

Cell and Gene Therapies News Round-Up: October 11

Image
4 October 2024

Cell and Gene Therapies News Round-Up: October 4

Image
24 September 2024

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 

The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
23 November 2022
The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
Late-stage clinical trial company CellVax
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
24 August 2022
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
bluebird bio has announced that
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Cell and Gene Therapies News Round-Up: October 11

Image

Cell and Gene Therapies News Round-Up: October 4

Image

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing